|
|
|
Drug Information Association, Online
Sep 28 2006
DIA Webinar offer the power and punch of in-person events—all from the convenience of your home or office. This 90-minute, introductory webinar will outline the benefits of a finalized Best Practices Document for the Submission of Data in a Voluntary Genomics Data Submission (VGDS)—the perfect appetizer for DIA’s upcoming two-day workshop, “Best Practices and Development of Standards for the Submission of genomic Data to the FDA.” Webinar Highlights: Panel discussion and Q&A with FDA representatives. Spirited discussion of the VGDS experience.FEATURED TOPICS: • Scientific accomplishments showcased in Voluntary Genomic Data Submissions (VGDS) over the past two years. • Consensus from Q&A sessions about the added value of genomic data in regulatory review. • New applications associated with VGDS, including other omic platforms and estimates for the impact of pharmacogenomic information in clinical trials. • Role of VGDS in the Biomarker Qualification Pilot Process. • Best Practices and Development of Standards in the Submission of Genomic Data to the FDA.
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
Invited Speakers:
|
|
FEDERICO GOODSAID, PHD Senior Staff Scientist, Genomics Office of Clinical Pharmacology CDER, FDAFELIX W. FRUEH, PHD Associate Director, Genomics Office of Clinical Pharmacology CDER, FDA
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/product/12215/06244.pdf
|
|
E-mail:
|
|
dia@diahome.org
|
|
|
|
|
|
|
|